UNITED STATES


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 10-Q

 

 

S  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2010

OR

£   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ____________

 

 

Commission file number    001–13489       

[nhcmarch2010form10q001.jpg]

(Exact name of registrant as specified in its Charter)

 

 

Delaware

52–2057472

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization

Identification No.)

 

 

100 E. Vine Street

Murfreesboro, TN

37130

(Address of principal executive offices)

(Zip Code)

 

 

(615) 890–2020

Registrant=s telephone number, including area code

 

 

Indicate by check mark whether the registrant: (1) Has filed all reports required to be filed by Section 13 or 15(d), of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  S No. £


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such period that the registrant was required to submit and post such files).

Yes £      No  £


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated file,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):  

Large Accelerated filer  £

Accelerated filer  S

 

 

Non-accelerated filer (Do not check if a smaller reporting company)  £

Smaller reporting company  £

 

Indicate by check mark whether the registrant is a shell company (as is defined in Rule 12b–2 of the Exchange

Act).  Yes  £   No S

 

13,748,365 shares of common stock of the registrant were outstanding as of April 28, 2010.




PART I.  FINANCIAL INFORMATION


Item 1.  Financial Statements.


NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Statements of Income

(Unaudited)

(in thousands, except share and per share amounts)



 

 

 

 

 

Three Months Ended

March 31

 

 

 

 

 

2010

 

 

2009

Revenues:

 

 

 

 

 

 

 

Net patient revenues

 

$

157,961

 

$

153,067 

 

Other revenues

 

 

14,076

 

 

11,622 

 

 

Net revenues

 

 

172,037

 

 

164,689 

 

 

 

 

 

 

 

 

 

Costs and Expenses:

 

 

 

 

 

 

 

Salaries, wages and benefits

 

 

96,076

 

 

90,726 

 

Other operating

 

 

49,003

 

 

47,968 

 

Rent

 

 

8,178

 

 

7,968 

 

Depreciation and amortization

 

 

6,427

 

 

6,243 

 

Interest

 

 

114

 

 

207 

 

 

Total costs and expenses

 

 

159,798

 

 

153,112 

 

 

 

 

 

 

 

 

 

Income Before Non-Operating Income

 

 

12,239

 

 

11,577

Non-Operating Income

 

 

4,575

 

 

3,980

 

 

 

 

 

 

 

 

 

Income Before Income Taxes

 

 

16,814

 

 

15,557 

Income Tax Provision

 

 

(6,407)

 

 

(6,373)

Net Income

 

 

10,407

 

 

9,184 

 

 

 

 

 

 

 

 

 

Dividends to Preferred Stockholders

 

 

(2,168)

 

 

(2,168)

 

 

 

 

 

 

 

 

 

Net Income Available to Common Stockholders

 

$

8,239

 

$

7,016 

 

 

 

 

 

 

 

 

 

Earnings Per Common Share:

 

 

 

 

 

 

 

Basic

 

$

.60

 

$

.53 

 

Diluted

 

$

.60

 

$

.53 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding:

 

 

 

 

 

 

 

Basic

 

 

13,721,570

 

 

13,228,845 

 

Diluted

 

 

13,725,201

 

 

13,254,437 







The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.



2





NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Balance Sheets

 (in thousands)



 

 

March 31, 2010

 

December 31

2009

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

27,789 

 

$

39,022 

 

 

Restricted cash and cash equivalents

 

 

55,515 

 

 

96,934 

 

 

Marketable securities

 

 

74,358 

 

 

71,280 

 

 

Restricted marketable securities

 

 

66,514 

 

 

19,350 

 

 

Accounts receivable, less allowance for doubtful accounts of $4,009 and $3,502, respectively

 

 

67,915 

 

 

62,129 

 

 

Inventories

 

 

7,641 

 

 

7,393 

 

 

Prepaid expenses and other assets

 

 

2,679 

 

 

1,074 

 

 

Federal income tax receivable

 

 

– 

 

 

3,470 

 

 

 

Total current assets

 

 

302,411 

 

 

300,652 

 

 

 

 

 

 

 

 

 

 

 

Property and Equipment:

 

 

 

 

 

 

 

 

Property and equipment, at cost

 

 

613,703 

 

 

608,753 

 

 

Accumulated depreciation and amortization

 

 

(187,856)

 

 

(181,177)

 

 

 

Net property and equipment

 

 

425,847 

 

 

427,576 

 

 

 

 

 

 

 

 

 

 

 

Other Assets:

 

 

 

 

 

 

 

 

Deposits

 

 

415 

 

 

323 

 

 

Goodwill

 

 

5,978 

 

 

5,978 

 

 

Notes receivable

 

 

26,257 

 

 

26,805 

 

 

Deferred income taxes

 

 

16,106 

 

 

15,555 

 

 

Investments in limited liability companies and other

 

 

12,900 

 

 

11,643 

 

 

 

Total other assets

 

 

61,656 

 

 

60,304 

 

 

 

Total assets

 

$

789,914 

 

$

788,532 

















The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.


The interim condensed consolidated balance sheet at December 31, 2009 is taken from the audited consolidated financial statements at that date.



3




NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)



 

 

 

March 31, 2010

 

 

December 31,

2009

 

 

 

(unaudited)

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Trade accounts payable

 

$

11,986

 

$

10,909 

 

 

Accrued payroll

 

 

30,523

 

 

46,149 

 

 

Amounts due to third party payors

 

 

19,520

 

 

18,617 

 

 

Accrued risk reserves

 

 

110,821

 

 

107,456 

 

 

Deferred income taxes

 

 

9,347

 

 

8,427 

 

 

Other current liabilities

 

 

15,154

 

 

15,117 

 

 

Dividends payable

 

 

5,740

 

 

5,729 

 

 

Accrued interest

 

 

10

 

 

81 

 

 

 

Total current liabilities

 

 

203,101

 

 

212,485 

 

 

 

 

 

 

 

 

 

 

 

Long-Term Debt, less Current Portion

 

 

10,000

 

 

10,000 

 

Other Noncurrent Liabilities

 

 

23,139

 

 

22,633 

 

Deferred Lease Credits

 

 

2,120

 

 

2,423 

 

Deferred Revenue

 

 

18,310

 

 

15,212 

 

 

 

 

 

 

 

 

 

 

 

Commitments, Contingencies and Guarantees

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

 

 

Series A Convertible Preferred Stock; $.01 par value; 25,000,000 shares authorized; 10,841,062 shares issued and outstanding; stated at liquidation of $15.75 per share

 

 

170,555

 

 

170,555 

 

 

Common stock, $.01 par value; 30,000,000 shares authorized; 13,737,679 and 13,717,701 shares, respectively, issued and outstanding

 

 

137

 

 

137 

 

 

Capital in excess of par value

 

 

131,566

 

 

130,867 

 

 

Retained earnings

 

 

201,807

 

 

197,140 

 

 

Unrealized gains on marketable securities, net of taxes

 

 

29,179

 

 

27,080 

 

 

 

Total stockholders’ equity

 

 

533,244

 

 

525,779 

 

 

 

Total liabilities and stockholders’ equity

 

$

789,914

 

$

788,532 








The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.


The interim condensed consolidated balance sheet at December 31, 2009 is taken from the audited consolidated financial statements at that date.




4




NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Statements of Cash Flows

(Unaudited)



 

 

 

Three Months Ended

March 31

 

 

 

2010

 

 

2009

Cash Flows From Operating Activities:

 

 

(in thousands)

 

Net income

 

$

10,407 

 

$

9,184 

 

Adjustments to reconcile net income to net cash

 

 

 

 

 

 

 

 

provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

6,427 

 

 

6,243 

 

 

Provision for doubtful accounts receivable

 

 

507 

 

 

170 

 

 

Amortization of deferred charges

 

 

(33)

 

 

(68)

 

 

Equity in earnings of unconsolidated investments

 

 

(2,258)

 

 

(2,003)

 

 

Distributions from unconsolidated investments

 

 

1,024 

 

 

67 

 

 

Deferred income taxes

 

 

(950)

 

 

(1,142)

 

 

Stock-based compensation

 

 

24 

 

 

339 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Restricted cash and cash equivalents

 

 

(5,407)

 

 

(550)

 

 

 

Accounts (and other) receivable

 

 

(6,293)

 

 

3,001 

 

 

 

Income tax receivable

 

 

3,470 

 

 

– 

 

 

 

Inventories

 

 

(248)

 

 

358 

 

 

 

Prepaid expenses and other assets

 

 

(1,605)

 

 

(1,124)

 

 

 

Trade accounts payable

 

 

1,077 

 

 

2,531 

 

 

 

Accrued payroll

 

 

(15,626)

 

 

(17,920)

 

 

 

Amounts due to third party payors

 

 

903 

 

 

68 

 

 

 

Accrued interest

 

 

(71)

 

 

(28)

 

 

 

Other current liabilities and accrued risk reserves

 

 

3,402 

 

 

2,028 

 

 

 

Entrance fee deposits

 

 

(201)

 

 

(254)

 

 

 

Other noncurrent liabilities

 

 

506 

 

 

93 

 

 

 

Deferred income

 

 

3,332 

 

 

3,485 

 

 

 

 

Net cash (used in) provided by operating activities

 

 

(1,613)

 

 

4,478 

Cash Flows From Investing Activities:

 

 

 

 

 

 

 

 

Additions to and acquisitions of property and equipment

 

 

(5,001)

 

 

(9,456)

 

 

Investments in notes receivable

 

 

– 

 

 

(11)

 

 

Collections of notes receivable

 

 

548 

 

 

3,166 

 

 

Decrease in restricted cash and cash equivalents

 

 

46,826

 

 

– 

 

 

Purchase of restricted marketable securities

 

 

(52,699)

 

 

– 

 

 

Sale of restricted marketable securities

 

 

5,875 

 

 

– 

 

 

Changes in cash fund in liquidation

 

 

– 

 

 

2,186 

 

 

 

 

Net cash used in investing activities

 

 

(4,451)

 

 

(4,115)

Cash Flows From Financing Activities:

 

 

 

 

 

 

 

 

Payments on debt

 

 

– 

 

 

(1)

 

 

Tax benefit from exercise of stock options

 

 

13 

 

 

3,499 

 

 

Dividends paid to preferred stockholders

 

 

(2,168)

 

 

(2,168)

 

 

Dividends paid to common stockholders

 

 

(3,561)

 

 

(3,123)

 

 

Issuance of common shares

 

 

662 

 

 

13,091 

 

 

Decrease (increase) in deposits

 

 

(92)

 

 

342 

 

 

Other

 

 

(23)

 

 

(418)

 

 

 

 

Net cash (used in) provided by financing activities

 

 

(5,169)

 

 

11,222 

Net (Decrease) Increase in Cash and Cash Equivalents

 

 

(11,233)

 

 

11,585 

Cash and Cash Equivalents, Beginning of Period

 

 

39,022 

 

 

49,033 

Cash and Cash Equivalents, End of Period

 

$

27,789 

 

$

60,618 


 

The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.





5




NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share and per share amounts)

(unaudited)


 

Preferred Stock

 

Common Stock

 

Capital in

Excess of

Par Value

 

Retained

Earnings

 

Unrealized

Gains (Losses) on

Marketable

Securities

 

Total

Stockholders’

Equity

 

Shares

 

Amount

 

Shares

 

Amount

 

 

 

 

 

 

 

 

Balance at December 31, 2008

10,841,062

$

170,555 

 

13,031,696

$

130 

$

113,580 

$

179,710 

$

16,842 

$

480,817 

 

Net income

– 

 

– 

 

– 

 

– 

 

– 

 

9,184 

 

– 

 

9,184 

 

Unrealized losses on securities (net of tax of $1,370)

– 

 

– 

 

– 

 

– 

 

– 

 

– 

 

(2,057)

 

(2,057)

 

Total comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,127 

 

Stock-based compensation

– 

 

– 

 

– 

 

– 

 

339 

 

– 

 

– 

 

339 

 

Tax benefit from exercise of stock options

– 

 

– 

 

– 

 

– 

 

1,575 

 

– 

 

– 

 

1,575 

 

Shares sold - options exercised

– 

 

– 

 

615,204 

 

 

13,085

 

– 

 

– 

 

13,091 

 

Dividends declared to preferred stockholders ($0.20 per share)

– 

 

– 

 

– 

 

– 

 

– 

 

(2,168)

 

– 

 

(2,168)

 

Dividends declared to common stockholders ($0.24 per share)

– 

 

– 

 

– 

 

– 

 

– 

 

(3,275)

 

– 

 

(3,275)

Balance at March 31, 2009

10,841,062

$

170,555 

 

13,646,900

$

136 

$

128,579 

$

183,451 

$

14,785 

$

497,506 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2009

10,841,062

$

170,555 

 

13,717,701

$

137 

$

130,867 

$

197,140 

$

27,080 

$

525,779 

 

Net income

– 

 

– 

 

– 

 

– 

 

– 

 

10,407 

 

– 

 

10,407 

 

Unrealized gains on securities (net of tax of $1,319)

– 

 

– 

 

– 

 

– 

 

– 

 

– 

 

2,099 

 

2,099 

 

Total comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,506 

 

Stock-based compensation

– 

 

– 

 

– 

 

– 

 

24

 

– 

 

– 

 

24 

 

Tax benefit from exercise of stock options

– 

 

– 

 

– 

 

– 

 

13

 

– 

 

– 

 

13 

 

Shares sold – options exercised

– 

 

– 

 

19,978

 

– 

 

662

 

– 

 

– 

 

662 

 

Dividends declared to preferred stockholders ($0.20 per share)

– 

 

– 

 

– 

 

– 

 

– 

 

(2,168)

 

– 

 

(2,168)

 

Dividends declared to common stockholders ($0.26 per share)

– 

 

– 

 

– 

 

– 

 

– 

 

(3,572)

 

– 

 

(3,572)

Balance at March 31, 2010

10,841,062

$

170,555 

 

13,737,679

$

137 

$

131,566 

$

201,807 

$

29,179 

$

533,244 


The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.




6




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Note 1 – Consolidated Financial Statements


The unaudited condensed consolidated financial statements to which these notes are attached include, in our opinion, all normal, recurring adjustments which are necessary to fairly present the financial position, results of operations and cash flows of National HealthCare Corporation (“NHC@ or the “Company”).  We assume that users of these interim financial statements have read or have access to the audited December 31, 2009 consolidated financial statements and Management=s Discussion and Analysis of Financial Condition and Results of Operations and that the adequacy of additional disclosure needed for a fair presentation, except in regard to material contingencies, may be determined in that context.  Accordingly, footnotes and other disclosures which would substantially duplicate the disclosure contained in our most recent annual report to stockholders have been omitted.  This interim financial information is not necessarily indicative of the results that may be expected for a full year for a variety of reasons.  Our audited December 31, 2009 consolidated financial statements are available at our web site: www.nhccare.com.


Reclassifications –


The 2010 and 2009 financial information has been reclassified so the basis of presentation is consistent with that of the 2010 financial information.  Specifically, the Company reclassified “non-operating income” out of “other revenues” in the Consolidated Statements of Income.



Note 2 – Other Revenues


Other revenues are outlined in the table below.  Revenues from insurance services include premiums for workers’ compensation, health insurance, and professional liability insurance policies that our wholly-owned limited purpose insurance subsidiaries have written for certain long-term health care centers to which we provide management or accounting services. Revenues from management and accounting services include management and accounting fees and revenues from other services provided to managed and other long-term health care centers.  “Other” revenues include miscellaneous health care related earnings.


Other revenues include the following:


 

 

 

Three Months Ended

March 31

(in thousands)

 

 

2010

 

 

2009

Insurance services

 

$

4,389

 

$

4,276

Management and accounting services fees

 

 

6,207

 

 

3,862

Rental income

 

 

3,049

 

 

3,096

Other

 

 

431

 

 

388

 

 

$

14,076

 

$

11,622


Certain of our affiliates manage five long-term care centers owned by National Health Corporation (“National”).  During the three months ended March 31, 2010 and 2009, we recognized management fees and interest on management fees of $1,446,000 and $-0-, respectively.  


The unpaid fees from the five centers owned by National, because the amount collectable could not be reasonably determined when the management services were provided, and because we cannot estimate the timing or amount of expected future collections, will be recognized as revenues only when fixed or determinable and collectibility of these fees can be reasonably assured.  Under the terms of our management agreement with National, the payment of these fees to us may be subordinated to other expenditures of the five long-term care centers.  We continue to manage these centers so that we may be able to collect our fees in the future and because the incremental savings from discontinuing services to a center may be small compared to the potential benefit.  We may receive payment for the unrecognized management fees in whole or in part in the future only if cash flows from the operating and investing




7




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



activities of the five centers are sufficient to pay the fees.  There can be no assurance that such future improved cash flows will occur.  


Certain of our affiliates manage 15 long-term care centers that were previously owned by National Health Investors, Inc. (“NHI”).  During the three months ended March 31, 2010 and 2009, we recognized $1,257,000 and $738,000, respectively, of management fees and interest from these 15 long-term care centers.  


Of the total 15 centers managed, the management fee revenues from seven centers were currently paid and recognized on the accrual method in 2010 and 2009.  The fees from the remaining eight centers, because of insufficient historical collections and the lack of expected future collections, are recognized only when realized.  Under the terms of the management agreements, the payment of these fees to us may be subordinated to other expenditures of each of the long-term care centers.  Our affiliates continue to manage these centers so that we may be able to collect our fees in the future and because the incremental savings from discontinuing services to a center may be small compared to the potential benefit.  We may receive payment for the unrecognized management fees in whole or in part in the future only if cash flows from operating and investing activities of the centers are sufficient to pay the fees.  There can be no assurance that such future improved cash flows will occur.  



Note 3 - Non-Operating Income


Non-operating income is outlined in the table below.  Non-operating income includes dividends and other realized gains and losses on securities, interest income and equity in earnings of unconsolidated investments.  Our most significant equity method investment is a 50% ownership and voting interest in Caris HealthCare L.P., a business that specializes in hospice care services.  


 

 

 

Three Months Ended

March 31

 

 

 

2010

 

 

2009

(in thousands)

 

 

 

 

 

 

Equity in earnings of unconsolidated investments

 

$

2,258

 

$

2,003

Dividends and other net realized gains and losses on sales of securities

 

 

1,140

 

 

1,062

Interest income

 

 

1,177

 

 

915

 

 

$

4,575

 

$

3,980



Note 4 – Other Operating Expenses


Other operating expenses include the costs of care and services that we provide to the residents of our facilities and the costs of maintaining our facilities.  Our primary patient care costs include drugs, medical supplies, purchased professional services, food, professional insurance and licensing fees.  The primary facility costs include utilities and property insurance.



Note 5 – Earnings per Share


We compute earnings per share using the two-class method.  Under the two-class method, earnings per common share are computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the period.  





8




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



The following table summarizes the earnings and the weighted average number of common shares used in the calculation of basic and diluted earnings per share.


 

 

 

Three Months Ended

March 31

(in thousands, except for share and per share amounts)

 

2010

 

 

2009

Basic:

 

 

 

 

 

 

     Weighted average common shares outstanding

 

 

13,721,570

 

 

13,228,845

     Net income

 

$

10,407

 

$

9,184

     Dividends to preferred stockholders

 

 

2,168

 

 

2,168

     Net income available to common stockholders

 

 

8,239

 

 

7,016

     Earnings per common share, basic

 

$

.60

 

$

.53

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

     Weighted average common shares outstanding

 

 

13,721,570

 

 

13,228,845

     Dilutive effect of stock options

 

 

3,631

 

 

25,592

     Assumed average common shares outstanding

 

 

13,725,201

 

 

13,254,437

 

 

 

 

 

 

 

Net income available to common stockholders

 

$

8,239

 

$

7,016

 

 

 

 

 

 

 

Net income for diluted earnings per common share

 

 

8,239

 

 

7,016

Earnings per common share, diluted

 

$

.60

 

$

.53


In the above table, 356,791 shares and 269,245 shares of stock options have been excluded in the 2010 and 2009 three month periods, respectively and 2,623,971 of preferred stock potential common shares issuable upon the conversion of the preferred stock have been excluded for 2010 and 2009, due to their anti-dilutive impact.



Note 6 - Investments in Marketable Securities


Our investments in marketable securities include available for sale securities.  Realized gains and losses from securities sales are determined on the specific identification of the securities.


Marketable securities and restricted marketable securities consist of the following:


 

 

 

March 31, 2010

 

 

December 31, 2009

(in thousands)

 

 

Amortized

Cost

 

 

Fair

Value

 

 

Amortized

  Cost

 

 

Fair

Value

Investments available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable equity securities

 

$

29,604

 

$

74,358

 

$

29,604

 

$

71,280

Restricted investments available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

 

28,739

 

 

28,745

 

 

3,159

 

 

3,125

 

Commercial mortgage-backed securities

 

 

20,144

 

 

20,365

 

 

7,422

 

 

7,392

 

U.S. Treasury securities

 

 

10,760

 

 

10,701

 

 

8,918

 

 

8,833

 

U.S. government sponsored enterprise securities

 

 

5,379

 

 

5,396

 

 

– 

 

 

– 

 

State and municipal securities

 

 

1,301

 

 

1,307

 

 

– 

 

 

– 

 

 

 

$

95,927

 

$

140,872

 

$

49,103

 

$

90,630





9




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Included in the available for sale marketable equity securities are the following:


(in thousands, except share amounts)

 

 

March 31, 2010

 

December 31, 2009

 

 

Shares

 

 

Cost

 

 

Fair

Value

 

Shares

 

 

Cost

 

 

Fair

Value

NHI Common Stock

 

1,630,642

 

$

24,734

 

$

63,204

 

1,630,642

 

$

24,734

 

$

60,317


The amortized cost and estimated fair value of debt securities classified as available for sale, by contractual maturity, are as follows:


 

 

 

March 31, 2010

 

 

December 31, 2009

(in thousands)

 

 

  Cost  

 

 

Fair Value

 

 

  Cost  

 

 

Fair

Value

Maturities:

 

 

 

 

 

 

 

 

 

 

 

 

Within 1 year

 

$

375

 

$

378

 

$

1,475 

 

$

1,493 

1 to 5 years

 

 

33,907

 

 

33,891

 

 

13,105 

 

 

12,984 

6 to 10 years

 

 

14,000

 

 

14,015

 

 

4,919 

 

 

4,873 

Over 10 years

 

 

18,041

 

 

18,230

 

 

– 

 

 

– 

 

 

$

66,323

 

$

66,514

 

$

19,499 

 

$

19,350 


Gross unrealized gains related to available for sale securities are $44,987,000 and $41,676,000 as of March 31, 2010 and December 31, 2009, respectively.  Gross unrealized losses related to available for sale securities were $42,000 and $149,000 as of March 31, 2010 and December 31, 2009, respectively.


Proceeds from the sale of investments in marketable securities during the periods ended March 31, 2010 and March 31, 2009 were $5,875,000, and $-0-, respectively.  Gross investment gains of $38,000 were realized on these sales during the period ended March 31, 2010.



Note 7 - Fair Value Measurements


The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable, and accounts payable approximate fair value due to their short-term nature.  The estimated fair value of notes receivable approximates the carrying value based principally on their underlying interest rates and terms, maturities, collateral and credit status of the receivables.  Our long-term debt approximates fair value due to variable interest rates.  At March 31, 2010 and December 31, 2009, there were no material differences between the carrying amounts and fair values of NHC’s financial instruments.    


The accounting standard for fair value measurements provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements.  Fair value is defined as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date.  This accounting standard establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs, where available.  The following summarizes the three levels of inputs that may be used to measure fair value:


Level 1 – The valuation is based on quoted prices in active markets for identical instruments.

Level 2 – The valuation is based on observable inputs such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.  

Level 3 – The valuation is based on unobservable inputs that are supported by minimal or no market activity and that are significant to the fair value of the instrument.  Level 3 valuations are typically performed using pricing




10




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



models, discounted cash flow methodologies, or similar techniques that incorporate management’s own estimates of assumptions that market participants would use in pricing the instrument, or valuations that require significant management judgment or estimation.


A financial instrument’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.  


The Company determines fair value for marketable securities with Level 1 inputs through quoted market prices.  The Company determines fair value for marketable securities with Level 2 inputs through broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency.  Our Level 2 marketable securities have been initially valued at the transaction price and subsequently valued, at the end of each month, typically utilizing third party pricing services or other market observable data.  The pricing services utilize industry standard valuation models, including both income and market based approaches and observable market inputs to determine value.  These observable market inputs include reportable trades, benchmark yields, credit spreads, broker/dealer quotes, bids, offers, and other industry and economic events.  We did not have any significant transfers of assets between Level 1 and Level 2 of the fair value measurement hierarchy during the three months ended March 31, 2010.  


The following table summarizes fair value measurements by level at March 31, 2010 and December 31, 2009 for assets and liabilities measured at fair value on a recurring basis (in thousands):


 

 

Fair Value Measurements Using

March 31, 2010

 

Fair

Value

 

Quoted Prices in Active Markets

For Identical Assets

(Level 1)

 

Significant Other Observable Inputs (Level 2)

 

Significant Unobservable Inputs

(Level 3)

Restricted cash and cash equivalents

$

43,379

$

43,379

$

– 

$

– 

Marketable equity securities

 

74,358

 

74,358

 

– 

 

– 

Corporate debt securities

 

28,745

 

– 

 

28,745

 

– 

Commercial mortgage-backed securities

 

20,365

 

– 

 

20,365

 

– 

U.S. Treasury securities

 

10,701

 

10,701

 

– 

 

– 

U.S. government sponsored enterprise securities

 

5,396

 

– 

 

5,396

 

– 

State and municipal securities

 

1,307

 

– 

 

1,307

 

– 

Total financial assets

$

184,251

$

128,438

$

55,813

$

– 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements Using

December 31, 2009

 

Fair

Value

 

Quoted Prices in Active Markets

For Identical Assets

(Level 1)

 

Significant Other Observable Inputs (Level 2)

 

Significant Unobservable Inputs

(Level 3)

Restricted cash and cash equivalents

$

72,301

$

72,301

$

– 

$

– 

Marketable equity securities

 

71,280

 

71,280

 

– 

 

– 

Corporate debt securities

 

3,125

 

3,125

 

– 

 

– 

Commercial mortgage-backed securities

 

7,392

 

– 

 

7,392

 

– 

U.S. Treasury securities

 

8,833

 

8,833

 

– 

 

– 

Total financial assets

$

162,931

$

155,539

$

7,392

$

– 




11




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Note 8 - Long-Term Debt and Commitments


Long-Term Debt—


Long-term debt consists of the following:


 

 

Weighted

Average

Interest Rate

 

Maturities

 

 

Long-Term Debt

(dollars in thousands)

 

 

 

 

 

 

3/31/10

 

 

12/31/09

 

 

 

 

 

 

 

 

 

 

 

Revolving Credit Facility, interest payable monthly

 

Variable,

1.24%

 

2010

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Unsecured term note payable to National, interest payable quarterly, principal payable at maturity

 

Variable,

2.8%

 

2018

 

 

10,000 

 

 

10,000 

 

 

 

 

 

 

 

10,000 

 

 

10,000 

Less current portion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

10,000 

 

$

10,000 



Note 9 - $75,000,000 Revolving Credit Facility


 Effective October 27, 2009, we extended the maturity of our Credit Agreement (the “Credit Agreement”) with Bank of America, N.A., as lender (the “Lender”).  The Credit Agreement provides for a $75,000,000 revolving credit facility (the “Credit Facility”), of which up to $5,000,000 may be utilized for letters of credit.  


Borrowings bear interest at either (i) the Eurodollar rate plus 1.00% or (ii) the prime rate.  Letter of credit fees are equal to 1.00% times the maximum amount available to be drawn under outstanding letters of credit.  Prior to the extension, the borrowing bore interest at either (i) the Eurodollar rate plus 0.375% or (ii) the prime rate.


Beginning October 27, 2009, commitment fees are payable on the daily unused portion of the Credit Facility at a rate of twenty (20) basis points per annum.  NHC is permitted to prepay the loans outstanding under the Credit Facility at any time, without penalty.  


The Credit Facility matures on October 26, 2010.  Between 90 and 120 days prior to the maturity date, NHC may request the extension of the maturity date.  If the Lender elects to consent to such extension, subject to certain conditions, the maturity date will be extended to the date which is 364 days after the then maturity date.


 NHC’s obligations under the Credit Agreement are guaranteed by certain NHC subsidiaries and are secured by pledges by NHC and the guarantors of (i) 100% of the equity interests of domestic subsidiaries and (ii) up to 65% of the voting equity interests and 100% of the non-voting equity interests of foreign subsidiaries, in each case, held by NHC or the guarantors.


The Credit Agreement contains customary representations and warranties, and covenants, including covenants that restrict, among other things, asset dispositions, mergers and acquisitions, dividends, restricted payments, debt, liens, investments and affiliate transactions.  The Credit Agreement contains customary events of default.


The Credit Facility is available for general corporate purposes, including working capital and acquisitions.




12




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)





Note 10 – Stock Option Plans


Our stockholders approved the 2005 Stock Option, Employee Stock Purchase, Physician Stock Purchase and Stock Appreciation Rights Plan (the APlan@) which provides for the grant of stock options to key employees, directors and non–employee consultants.  Under the Plan, the Compensation Committee of the Board of Directors (Athe Committee@) has the authority to select the participants to be granted options; to designate whether the option granted is an incentive stock option (AISO@), a non–qualified option, or a stock appreciation right; to establish the number of shares of common stock that may be issued upon exercise of the option; to establish the vesting provision for any award; and to establish the term any award may be outstanding.  The exercise price of any ISO=s granted will not be less than 100% of the fair market value of the shares of common stock on the date granted and the term of an ISO may not be any more than ten years.  The exercise price of any non–qualified options granted will not be less than 100% of the fair market value of the shares of common stock on the date granted unless so determined by the Committee.  


The Company is required to estimate the fair value of share-based awards on the date of grant.  The fair value of each option award is estimated using the Black–Scholes option valuation model with the weighted average assumptions indicated in the following table.  Generally, awards are subject to cliff vesting.  Each grant is valued as a single award with an expected term based upon expected employment and termination behavior.  Compensation cost is recognized as “Salaries, wages and benefits” in the Consolidated Statements of Income over the requisite service period in a manner consistent with the option vesting provisions.  The straight–line attribution method requires that compensation expense is recognized at least equal to the portion of the grant–date fair value that is vested at that date.  The expected volatility is derived using weekly historical data for periods immediately preceding the date of grant.  The risk–free interest rate is the approximate yield on the United States Treasury Strips having a life equal to the expected option life on the date of grant.  The expected life is an estimate of the number of years an option will be held before it is exercised.  The following table summarizes the assumptions used to value the options granted in the periods shown.



 

 

Three Months Ended

March 31

 

 

2010

 

2009

Risk-free interest rate

 

0.45%

 

4.00%

Expected volatility

 

31.9%

 

32.9%

Expected life, in years

 

1.0 years

 

1.0 years

Expected dividend yield

 

3.07%

 

2.07%

Expected forfeiture rate

 

0.00%

 

0.00%





13




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



The following table summarizes option activity:  


 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2008

 

992,196 

 

$

30.55

 

 

− 

Options granted

 

113,914 

 

 

37.37

 

 

− 

Options exercised

 

(685,805)

 

 

22.44

 

 

− 

Options cancelled

 

(35,000)

 

 

55.00

 

 

− 

Options outstanding at December 31, 2009

 

385,305 

 

 

44.78

 

 

− 

Options granted

 

23,464 

 

 

36.85

 

 

− 

Options exercised

 

(19,978)

 

 

33.14

 

 

− 

Options outstanding at March 31, 2010

 

388,791 

 

$

44.90

 

$

(3,701,000)

 

 

 

 

 

 

 

 

 

Options exercisable at March 31, 2010

 

365,327 

 

$

45.42

 

$

(3,664,000)



Options

Outstanding

March 31, 2010

 

Exercise Prices

 

Weighted Average

Exercise Price

 

Weighted Average

Remaining Contractual

Life in Years

138,171

 

$32.01 to $37.70

 

36.24

 

2.6

250,620

 

$44.25 to $52.50

 

49.67

 

2.1

388,791

 

 

 

 

 

 



At March 31, 2010, 365,327 options outstanding are exercisable.  Exercise prices on the options range from $32.01 to $52.50.  The weighted average remaining contractual life of options outstanding at March 31, 2010 is 2.3 years.  The weighted average fair value of options granted during the three months ended March 31, 2010 and 2009 were $4.14 ($97,000 in total) and $6.13 ($114,000 in total) per share, respectively.  The total intrinsic value of shares exercised during the three months ended March 31, 2010 and 2009 was $60,000 and $11,609,000, respectively.


Additionally, the Plan allows employees to purchase our shares of stock through payroll deductions.  Employees may terminate participation at any time.


Our policy is to issue new shares to satisfy share option exercises.  In addition to the stock options issued and outstanding under the Plan, we have reserved an additional 787,738 shares of common stock for issuance under the Plan.


NHC recognized $24,000 and $339,000 of share-based compensation expense for the three month periods ended March 31, 2010 and 2009, respectively.  Current accounting guidance requires the benefits of tax deductions in excess of amounts recognized as compensation cost be reported as a financing cash flow, rather than an operating cash flow, as required under prior accounting guidance.  Tax deductions in excess of amounts recognized as compensation costs totaled $57,000 and $8,747,000 for the three months ended March 31, 2010 and 2009, respectively.  No share based compensation cost was capitalized during the current periods.  The total compensation cost related to non–vested awards not yet recognized at March 31, 2010 is $73,000 and the weighted average period over which it is to be recognized is .75 years.






14




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Note 11 – Accounting for Uncertainty in Income Taxes


NHC continually evaluates for uncertain tax positions.  Uncertain tax positions may arise where tax laws may allow for alternative interpretations or where the timing of recognition of income is subject to judgment.  We believe we have made adequate provision for unrecognized tax benefits related to uncertain tax positions.  However, because of uncertainty of interpretation by various tax authorities and the possibility that there are issues that have not been recognized by management, we cannot guarantee we have accurately estimated our tax liabilities.  We believe that our liabilities reflect the anticipated outcome of known uncertain tax positions in conformity with ASC Topic 740, Income Taxes (previously FIN 48, “Accounting for Uncertainty of Income Taxes – an interpretation of SFAS No. 109”).  Our liabilities for unrecognized tax benefits are presented in the consolidated balance sheets within Other Noncurrent Liabilities.


At March 31, 2010, we had $17,650,000 of unrecognized tax benefits, composed of $10,992,000 of deferred tax assets, $-0- of deferred tax liabilities, and $6,658,000 of permanent differences.  Accrued interest and penalties of $5,489,000 relate to unrecognized tax benefits at March 31, 2010.  Unrecognized tax benefits of $6,658,000, net of federal benefit, at March 31, 2010, attributable to permanent differences, would favorably impact our effective tax rate if recognized.  Accrued interest and penalties of $2,654,000 relate to these permanent differences at March 31, 2010.  We do not expect to recognize significant increases or decreases in unrecognized tax benefits within twelve months of March 31, 2010, except for the effect of decreases related to the lapse of statute of limitations estimated at $2,546,000, composed of temporary differences of $-0-, and permanent tax differences of $2,546,000.  Interest and penalties of $1,156,000 relate to these permanent difference changes within 12 months of March 31, 2010.  


Interest and penalties expense related to U.S. federal and state income tax returns are included within income tax expense.  


The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2006 (with certain state exceptions). Currently, there are no U.S. federal or state returns under examination.  



Note 12 – Guarantees and Contingencies


Accrued Risk Reserves


 

We are self insured for risks related to health insurance and have wholly-owned limited purpose insurance companies that insure risks related to workers’ compensation and general and professional liability insurance claims both for our owned or leased entities and certain of the entities to which we provide management or accounting services.  The liability we have recognized for reported claims and estimates for incurred but unreported claims totals $110,821,000   and $107,456,000 at March 31, 2010 and December 31, 2009, respectively.  This liability is classified as a current liability based on the uncertainty regarding the timing of potential payments.  The liability is included in accrued risk reserves in the consolidated balance sheets and is subject to adjustment for actual claims incurred.  It is possible that these claims plus unasserted claims could exceed our insurance coverages and our reserves, which would have a material adverse effect on our financial position, results of operations and cash flows.


As a result of the terms of our insurance policies and our use of wholly-owned limited purpose insurance companies, we have retained significant insurance risk with respect to workers’ compensation and general and professional liability.  We use independent actuaries to estimate our exposures for claims obligations (for both asserted and unasserted claims) related to deductibles and exposures in excess of coverage limits, and we maintain reserves for these obligations.  Such estimates are based on many variables including historical and statistical information and other factors.  





15




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Workers’ Compensation


For workers’ compensation, we utilize a wholly-owned Tennessee domiciled property/casualty insurance company to write coverage for NHC affiliates and for third-party customers.  Policies are written for a duration of twelve months and cover only risks related to workers’ compensation losses.  All customers are companies which operate in the long-term care industry.  Business is written on a direct basis.  Direct business coverage is written for statutory limits and the insurance company’s losses in excess of $1,000,000 per claim are covered by reinsurance.  


For these workers’ compensation insurance operations, the premium revenues reflected in the consolidated financial statements within “Other Revenues” for the three months ended March 31, 2010 and 2009, respectively, are $1,299,000 and $1,318,000.  Associated losses and expenses are reflected in the consolidated financial statements as “Other operating costs and expenses”.


General and Professional Liability Lawsuits and Insurance


Across the nation, the entire long term care industry has experienced significant amounts of personal injury/wrongful death claims and awards based on alleged negligence by nursing facilities and their employees in providing care to residents.  As of March 31, 2010, we and/or our managed centers are currently defendants in 38 such claims covering the years 1999 through March 31, 2010.   


Due to either the unavailability and/or prohibitive cost of quoted professional liability insurance coverage in 2002, we elected to pay the premiums into a wholly-owned licensed captive insurance company, incorporated in the Cayman Islands, for the purpose of managing our losses related to these risks.  Thus, for the years 2002-2010, insurance coverage for incidents occurring at all providers owned or leased, and most providers managed by us, is provided through this wholly-owned insurance company.  Current policies are written for a duration of twelve months.  


Our insurance coverage for all years includes both primary and excess policies. In 2002, deductibles were eliminated and first dollar coverage was provided through the wholly-owned insurance company, while the excess coverage was provided by a third party insurer.    


For 2003-2010, both primary professional liability insurance coverage and excess coverage is provided through our wholly-owned liability insurance company in the amount of $1 million per incident, $3 million per location with an aggregate primary policy limit.  The limit was $17.0 million for the years 2010 and 2009, and $16.0 million for 2008.  There is a $9.0 million annual excess aggregate applicable to years 2008, 2009 and 2010.


For these professional liability insurance operations, the premium revenues reflected in the consolidated financial statements within “Other revenues” for the three months ended March 31, 2010 and 2009, respectively, are $1,111,000 and $1,162,000.  Associated losses and expenses including those for self-insurance are included in the consolidated financial statements as “Other operating costs and expenses”.  


Other Matters


On July 24, 2009, the Company received a civil investigative demand from the Tennessee Attorney General’s Office, requesting production of documents related to NHC’s business relationships with non-profit entities.  The Company is in the process of responding to the demand and will comply as required with the terms of the demand.






16




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Note 13 – Subsequent Event


Effective May 1, 2010, we purchased for $14,850,000 in cash certain assets and assumed certain liabilities of three home health care (we call them homecare) programs located in South Carolina.  The three homecare programs are licensed in five South Carolina counties.



Note 14 – New Accounting Pronouncements


In February 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2010-09, which is included in the Codification under ASC Topic 855, Subsequent Events.  This update removes the requirement for an SEC filer to disclose the date through which subsequent events have been evaluated and became effective immediately.  The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.  


In January 2010, the FASB issued ASU No. 2010-06, which is included in the Codification under ASC Topic 820, Fair Value Measurements and Disclosures.  This update requires the disclosure of transfers between the observable input categories and activity in the unobservable input category for fair value measurements.  The guidance also requires disclosures about the inputs and valuation techniques used to measure fair value and became effective for our interim and annual reporting periods beginning January 1, 2010.  The adoption of this guidance is reflected in Note 7 – Fair Value Measurements.   


In June 2009, the FASB issued ASU No. 2009-17, which is included in the Codification under ASC Topic 810, Consolidation (previously SFAS No. 167, “Amendments to FASB Interpretation No. 46(R)”).  This updated guidance requires an analysis to determine whether a variable interest gives the entity a controlling financial interest in a variable interest entity.  It also requires an ongoing reassessment and eliminates the quantitative approach previously required for determining whether an entity is the primary beneficiary.  This update is effective for our interim and annual reporting periods beginning January 1, 2010.  The adoption did not have a material impact on the Company’s consolidated financial statements.  



Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations.


Overview


National HealthCare Corporation (ANHC@ or the ACompany@) is a leading provider of long–term health care services.  We operate or manage, through certain affiliates, 77 long–term health care centers with 9,892 beds in 10 states and provide other services in two additional states.  These operations are provided by separately funded and maintained subsidiaries.  We provide long–term health care services to patients in a variety of settings including long–term nursing centers, managed care specialty units, sub–acute care units, Alzheimer's care units, hospice programs, homecare programs, assisted living centers and independent living centers.  In addition, we provide management and accounting services and lease properties to owners of long–term health care centers.



Summary of Goals and Areas of Focus


Earnings – To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues.  Inflationary increases in our costs may cause net earnings from patient services to decline.  





17




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Development and Growth – In January 2010, we opened a new 120-bed skilled care and dementia center in Bluffton, South Carolina.  In March 2010, we opened a new 45-unit assisted living community in Mauldin, South Carolina. We have also initiated construction of a new 75-unit assisted living community in Parklane, South Carolina, and a 46-unit addition to our current Franklin, Tennessee assisted living community. We have Certificates of Need for a 92-bed healthcare center in Hendersonville, Tennessee and a 60-bed healthcare center in Tullahoma, Tennessee.  These projects are in preparation for future development.  


We are continuing to develop an active hospice program in South Carolina independently of our partnership with Caris Healthcare and are also exploring opportunities to expand our home health care services.  In January 2009, we purchased five hospice locations in South Carolina and also opened a Greenville, South Carolina hospice location.   During 2010, we will apply for Certificates of Need for additional beds in select markets and new NHC construction opportunities for skilled nursing and assisted living facilities.  NHC will also continue to seek prudent acquisition opportunities in each of our lines of business.


Accrued Risk Reserves – Our accrued professional liability reserves, workers= compensation reserves and health insurance reserves totaled $110,821,000 at March 31, 2010 and are a primary area of management focus.  We have set aside restricted cash and cash equivalents and marketable securities to fund substantially all of our professional liability and workers= compensation reserves.  


As to exposure for professional liability claims, we have developed for our centers performance certification criteria to measure and bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents.  Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction.  Furthermore, we are continuing efforts to identify and restructure the ownership or management of our higher risk operations and locations to eliminate NHC liability exposure.



Application of Critical Accounting Policies


The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and cause our reported net income to vary significantly from period to period.


Our critical accounting policies that are both important to the portrayal of our financial condition and results and require our most difficult, subjective or complex judgments are as follows:  


Revenue Recognition – Third Party Payors – Approximately 64% (2009), 63% (2008), and 65% (2007) of our net revenues are derived from Medicare, Medicaid, and other government programs.  Amounts earned under these programs are subject to review by the Medicare and Medicaid intermediaries.  In our opinion, adequate provision has been made for any adjustments that may result from these reviews.  Any differences between our estimates of settlements and final determinations are reflected in operations in the year finalized.  At March 31, 2010, we have made provisions for amounts due third party payors of approximately $19,520,000.  Revenues and results of operations in the three months ended March 31, 2010 and 2009 were not materially impacted by changes in estimates of settlements and final determinations.


Revenue Recognition – Private Pay – For private pay patients in skilled nursing or assisted living facilities, we bill room and board in advance for the current month with payment being due upon receipt of the statement in the month




18




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



the services are performed.  Charges for ancillary, pharmacy, therapy and other services to private patients are billed in the month following the performance of services.  All billings are recognized as revenue when the services are performed.


Accrued Risk Reserves – We are principally self–insured for risks related to employee health insurance, workers= compensation and professional and general liability claims.  The accrued risk reserves include a liability for reported claims and estimates for incurred but unreported claims.  Our policy with respect to a significant portion of our workers= compensation and professional and general liability claims is to use an actuary to support the estimates recorded for incurred but unreported claims.  Our health insurance reserve is based on our known claims incurred and an estimate of incurred but unreported claims determined by our analysis of historical claims paid.  We reassess our accrued risk reserves on a quarterly basis.


Professional liability remains an area of particular concern to us.  The entire long term care industry has seen personal injury/wrongful death claims based on alleged negligence by nursing homes and their employees in providing care to residents.  As of March 31, 2010, we and/or our managed centers are defendants in 38 such claims inclusive of years 1999 through 2010.  It remains possible that these pending matters plus potential unasserted claims could exceed our reserves, which would have a material adverse effect on our financial position, results of operations and cash flows.   It is also possible that future events could cause us to make significant adjustments or revisions to these reserve estimates and cause our reported net income to vary significantly from period to period.  


We maintain insurance coverage for incidents occurring at all providers owned or leased by us, and most providers managed by us.  The coverages include both primary policies and excess policies.  In all years, settlements, if any, in excess of available insurance policy limits and our own reserves would be expensed by us.  


Revenue Recognition – Subordination of Fees and Uncertain Collections – We provide management services to certain long–term care facilities and to others we provide accounting and financial services.  We generally charge 6% of net revenues for our management services and a predetermined fixed rate per bed for the accounting and financial services. Our policy is to recognize revenues associated with both management services and accounting and financial services on an accrual basis as the services are provided.  However, under the terms of our management contracts, payments for our management services are subject to subordination to other expenditures of the long–term care center being managed.  Furthermore, there are certain of the third parties with whom we have contracted to provide services and which we have determined, based on insufficient historical collections and the lack of expected future collections, that collection is not reasonably assured and our policy is to recognize income only in the period in which the amounts are realized.  We recognize the expenses related to the provision of those services in the period in which they are incurred.  We may receive payment for the unpaid and unrecognized management fees in whole or in part in the future only if cash flows from the operating and investing activities of the centers are sufficient to pay the fees.  There can be no assurance that such future cash flows will occur.  The realization of such previously unrecognized revenue could cause our reported net income to vary significantly from period to period.


We agree to subordinate our fees to the other expenses of a managed center because we believe we know how to improve the quality of patient services and finances of a long–term care center and because subordinating our fees demonstrates to the owner and employees of the managed center how confident we are of the impact we can have in making the center operations successful.  We may continue to provide services to certain managed centers despite not being fully paid currently so that we may be able to collect unpaid fees in the future from improved operating results and because the incremental savings from discontinuing services to a center may be small compared to the potential benefit.  Also, we may benefit from providing other ancillary services to the managed center.  


Certain of our accounts receivable from private paying patients and certain of our notes receivable are subject to credit losses.  We have attempted to reserve for expected accounts receivable credit losses based on our past experience with similar accounts receivable and believe our reserves to be adequate.  





19




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



We continually monitor and evaluate the carrying amount of our notes receivable in accordance with ASC Topic 310, Receivables (previously SFAS No. 114, “Accounting by Creditors for Impairment of a Loan  - an Amendment of SFAS Nos. 5 and 15”) .  It is possible, however, that the accuracy of our estimation process could be materially impacted as the composition of the receivables changes over time.  We continually review and refine our estimation process to make it as reactive to these changes as possible.  However, we cannot guarantee that we will be able to accurately estimate credit losses on these balances.  It is possible that future events could cause us to make significant adjustments or revisions to these estimates and cause our reported net income to vary significantly from period to period.

 

Potential Recognition of Deferred Income - During 1988, we sold the assets of eight long-term health care centers to National Health Corporation (ANational@), our administrative general partner at the time of the sale.  The resulting profit of $15,745,000 was deferred.  $10,000,000 of the deferred gain and related deferred income taxes of $4,000,000 were recognized as income in December 2007 with the collection of the $10,000,000 note from National.  $3,745,000 of the deferred gain has been amortized into income on a straight-line basis over the 20-year management contract period.  Additional deferred income of $2,000,000 will be recognized when the Company no longer has an obligation to advance a $2,000,000 working capital loan which obligation has been extended until January 20, 2018 with the extension of the management agreement with National to that date.


Guarantees – At March 31, 2010, no agreements to guarantee debt of other parties are outstanding.


Uncertain Tax Positions –  NHC continually evaluates for uncertain tax positions.  These uncertain positions may arise where tax laws may allow for alternative interpretations or where the timing of recognition of income is subject to judgment.  We believe we have adequate provisions for our uncertain tax positions including related penalties and interest. However, because of uncertainty of interpretation by various tax authorities and the possibility that there are issues that have not been recognized by management, we cannot guarantee we have accurately estimated our tax liabilities.  


The above listing is not intended to be a comprehensive list of all of our accounting policies.  In many cases, the accounting treatment of a particular transaction is specifically dictated by generally accepted accounting principles, with no need for management=s judgment in their application.  There are also areas in which management=s judgment in selecting any available alternative would not produce a materially different result.  See our December 31, 2009 consolidated financial statements and notes thereto which contain accounting policies and other disclosures required by generally accepted accounting principles.  



Government Program Financial Changes


Cost containment will continue to be a priority for Federal and State governments for health care services, including the types of services we provide.  Government reimbursement programs such as Medicare and Medicaid prescribe, by law, the billing methods and amounts that health care providers may charge and be reimbursed to care for patients covered by these programs. Congress has passed a number of laws that have effected major changes in the Medicare and Medicaid programs. The Balanced Budget Act of 1997 sought to achieve a balanced federal budget by, among other things, reducing federal spending on Medicare and Medicaid to various providers.  In February 2006, Congress enacted the Deficit Reduction Act, or DRA, which reduced net Medicare and Medicaid spending, and in December 2006, Congress passed the Tax Relief and Health Care Act of 2006, which also affects payments under the Medicare and Medicaid programs.


Recent developments –


In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act (“PPACA”) and the Health Care and Education Reconciliation Act of 2010 (“HCERA”), which represents significant changes to the current U.S. health care system (collectively the “Acts”). The Acts affect aging services providers, our partners




20




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



(employees) and our patients and residents in a multitude of ways.  We are currently evaluating the provisions of the Acts and do not expect material effects on our results of operations, liquidity and cash flows in 2010.  Some of the details affecting skilled nursing providers include a Medicare market basket freeze for fiscal 2010, preservation of the Medicare market basket update for fiscal 2011, and the initiation of the Medicare productivity adjustment starting in fiscal 2012 (which is expected to cut the fiscal 2011 update by an estimated 1%).  The Acts also delay the start of the Medicare RUG-IV classification system until October 1, 2011.  For home-based and community-based services, Medicaid coverage has been expanded.


We anticipate that many of the provisions of the Acts may be subject to further clarification and modification through the rule-making process.  It is uncertain at this time the effect the modifications will have on our future results of operations or cash flows.  


Medicare—


Effective October 1, 2009, our PPS rates were decreased by a net of 1.1%. There was an inflationary increase of 2.2%, but there was also a recalibration of the nursing weights resulting in a reduction of 3.3%.  The net impact of the adjustments was a reduction of 1.1% to PPS rates.  The inflation update (or market basket increase) was 3.4% in 2008 and 3.3% in 2007.  


For the first three months of 2010, our average Medicare per diem rate decreased 2.6% from the same period of 2009.  No assurances can be given as to whether Congress will increase or decrease reimbursement in the future, the timing of any action or the form of relief, if any, that may be enacted.


Medicaid—


Tennessee annual Medicaid rate increases were implemented effective July 1, 2009.  Tennessee Medicaid only funded 20% of the normal rate increases for all skilled and intermediate providers.  We estimate the resulting increase in revenue from this payment source was approximately $89,000 per quarter.  


Missouri Medicaid funded a global rate increase for all providers of $6.15 per day effective July 1, 2009.  The quarterly effect of these rate increases was approximately $345,000.  


South Carolina annual Medicaid rate increases were implemented effective October 1, 2009.  We estimate the resulting increase in revenue was approximately $682,000 per quarter.


For the first three months of 2010, our average Medicaid per diem increased by 3.5% over the same period in 2009.  We face challenges with respect to states’ Medicaid payments because many states currently do not cover the total costs incurred in providing care to those patients. States will continue to control Medicaid expenditures but also look for adequate funding sources, including provider assessments.  The DRA includes several provisions designed to reduce or slow the rate of increase in Medicaid spending. These provisions include, among others, provisions strengthening the Medicaid asset transfer restrictions for persons seeking to qualify for Medicaid long-term care coverage, which could, due to the timing of the penalty period, increase facilities’ exposure to uncompensated care. Other provisions could increase state funding for home and community-based services, potentially having an impact on funding for nursing facilities. There is no assurance that the funding for our services will increase or decrease in the future.






21




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Results of Operations


Three Months Ended March 31, 2010 Compared to Three Months Ended March 31, 2009.


Results for the three month period ended March 31, 2010 include a 4.5% increase in net revenues and an 8.1% increase in income before taxes compared to the same period in 2009.  


Net patient revenues increased $4,894,000 or 3.2% compared to the same period last year. Medicare per diem rates decreased 2.6% compared to the quarter a year ago.  Medicaid and private pay per diem rates increased 3.5% and 4.0%, respectively, compared to the quarter a year ago.  Although our Medicare per diem rates decreased, our Medicare patient days increased 4.2%, which increased Medicare revenues 1.5% compared to the quarter a year ago.  Homecare operations also increased net patient revenues in the amount of $1,195,000 compared to the quarter a year ago.


The total census at owned and leased centers for the quarter averaged 92.4% (excluding the 120-bed Bluffton, South Carolina facility which opened January, 2010) compared to an average of 91.6% for the same quarter a year ago.


Other revenues increased $2,454,000 or 21.1% in the three-month 2010 period to $14,076,000 from $11,622,000 in the 2009 three-month period.  The increase in other revenues is primarily due from an increase in management and accounting services fees of $2,345,000.    


Non-operating income increased $595,000, or 15.0%, to $4,575,000 in the three-month 2010 period in comparison to the three-month 2009 period.  The increase is due to the increase in equity in earnings of our unconsolidated investment in Caris Healthcare, L.P. ($266,000) and interest income ($262,000).  


Total costs and expenses for the 2010 first quarter compared to the 2009 first quarter increased $6,686,000 or 4.4% to $159,798,000 from $153,112,000.  Salaries, wages and benefits, the largest operating costs of this service company, increased $5,350,000 or 5.9% to $96,076,000 from $90,726,000.  Other operating expenses increased $1,035,000 or 2.2% to $49,003,000 for the 2010 period compared to $47,968,000 for the 2009 period.  Rent expense increased $210,000 or 2.6% to $8,178,000 compared to $7,968,000 for the 2009 period.  Depreciation and amortization increased $184,000 or 3.0% to $6,427,000 from $6,243,000.  Interest costs decreased $93,000 to $114,000.  


Increases in salaries, wages and benefits are due to the increased staffing from the opening of our new 120-bed skilled care and dementia center in Bluffton, South Carolina and our new 45-unit assisted living community in Parklane, South Carolina ($715,000), increased costs for therapist services ($1,061,000), and inflationary increases.  The majority of the increase in other operating expenses was also due to the opening of the two new facilities mentioned above ($465,000). Depreciation expense increased primarily due to the two new facilities being placed into service during the first quarter of 2010.


The income tax provision for the three months ended March 31, 2010 is $6,407,000 (an effective income tax rate of 38.1% which is in line with management’s expectations).  The income tax provision and effective tax rate for 2010 were favorably impacted by permanent differences.  The income tax provision for the three months ended March 31, 2009 was $6,373,000 (an effective tax rate of 41.0%).   The income tax provision and effective tax rate for the three months ended 2009 were unfavorably impacted by permanent differences.

 

Liquidity, Capital Resources, and Financial Condition


Sources and Uses of Funds - Our primary sources of cash include revenues from the healthcare and senior living facilities we operate, insurance services, management services and accounting services.  Our primary uses of cash include salaries, wages and other operating costs of our home office and the facilities we operate, the cost of additions to and acquisitions of real property, rent expenses, and dividend distributions.  These sources and uses of cash are reflected in




22




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



our Consolidated Statements of Cash Flows and are discussed in further detail below.  The following is a summary of our sources and uses of cash flows (dollars in thousands):


 

 

 

Three Months Ended

March 31

 

 

Three Month Change

 

 

 

2010

 

 

2009

 

 

$

 

%

Cash and cash equivalents at beginning of period

 

$

39,022 

 

$

49,033 

 

$

(10,011)

 

(20.4)%

 

 

 

 

 

 

 

 

 

 

 

 

Cash provided from (used in) operating activities

 

 

(1,613)

 

 

4,478 

 

 

(6,091)

 

(136.0)%

 

 

 

 

 

 

 

 

 

 

 

 

Cash (used in) investing activities

 

 

(4,451)

 

 

(4,115)

 

 

(336)

 

(8.2)%

 

 

 

 

 

 

 

 

 

 

 

 

Cash provided from (used in) financing activities

 

 

(5,169)

 

 

11,222 

 

 

(16,391)

 

(146.1)%

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

27,789 

 

$

60,618 

 

$

(32,829)

 

(54.2)%


Operating Activities - Net cash used in operating activities for the three months ended March 31, 2010 was $1,613,000, as compared to $4,478,000 provided by operating activities in the same period last year. Cash used in operating activities for the current period were from increases in accounts receivable, restricted cash and cash equivalents, equity in earnings of unconsolidated investments, prepaid expenses, and a decrease in accrued payroll.  The decreases in operating activities were offset by increases in other current liabilities and accrued risk reserves, deferred income, accounts payable, and a decrease in income tax receivable.  The decrease in accrued payroll is due to the timing of payroll payments as well as payments of payroll taxes.  


Investing Activities - Cash used in investing activities totaled $4,451,000 and $4,115,000 for the three months ended March 31, 2010 and 2009, respectively.  Cash used for property and equipment additions was $5,001,000 for the three months ended March 31, 2010 and $9,456,000 in the comparable period in 2009.  Cash provided by net collections of notes receivable was $548,000 in 2010 compared to $3,166,000 in 2009. The enhanced cash fund balance was liquidated in December 2009; therefore, there was no activity during the first quarter of 2010.  Cash was used in purchasing marketable securities of $52,699,000 and cash was provided from the sale of marketable securities of $5,875,000 for the first three months of 2010.   The Company did not purchase or sell any securities for the three months ended March 31, 2009.  


Costs included in property and equipment additions include $1,905,000 for the completed 120-bed long-term health care center in Bluffton, South Carolina and $997,000 for the completed 45-unit assisted living community in Mauldin, South Carolina.  The purchases of marketable securities were funded from restricted cash balances to earn a better rate of return.


Financing Activities - Net cash used in financing activities totaled $5,169,000 in the three months ended March 31, 2010 compared to $11,222,000 net cash provided by financing activities in the same period in 2009.  Cash used for dividend payments to common and preferred stockholders totaled $5,729,000.  In the prior period, cash used for dividend payments to common and preferred stockholders totaled $5,291,000.  Tax benefits from exercise of stock options provided cash of $13,000 in 2010 and $3,499,000 in 2009.  In the current period, $662,000 of cash was provided by the issuance of common stock compared to $13,091,000 in the same period last year.   


At March 31, 2010 and December 31, 2009, our ratio of long–term debt to total capitalization (total debt plus deferred income plus stockholders equity) was 1.8%.






23




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Table of Contractual Cash Obligations


Our contractual cash obligations for periods subsequent to March 31, 2010 are as follows (in thousands):


 

 

Total

 

Less than

1 year

 

1-3

Years

 

3-5

Years

 

After

5 Years

Long-term debt principal

$

10,000 

$

− 

$

− 

$

− 

$

10,000 

Long-term debt – interest

 

2,141 

 

276 

 

553 

 

553 

 

759 

Obligations to complete construction

 

17,547 

 

17,547 

 

− 

 

− 

 

− 

Operating leases

 

395,975 

 

33,700 

 

67,400 

 

67,400 

 

227,475 

Total Contractual Cash Obligations

$

 425,663 

$

51,523 

$

67,953 

$

67,953 

$

238,234 


Other noncurrent liabilities for uncertain tax positions of $8,680,000, attributable to permanent differences, at March 31, 2010 has not been included in the above table because of the inability to estimate the period in which the tax payment is expected to occur.  See Note 11 of the Interim Condensed Consolidated Financial Statements for a discussion on income taxes.


We started paying quarterly dividends in the second quarter of 2004 and anticipate the continuation of dividend payments as approved quarterly by the Board of Directors.


Short-term liquidity


Effective October 27, 2009, we extended the maturity of our $75,000,000 revolving credit agreement to October 26, 2010.  We currently do not have any funds drawn against the credit agreement and the amount of $75,000,000 is available to be drawn for general corporate purposes, including working capital and acquisitions.


As to short-term liquidity commitments, we have entered into an agreement to complete construction of a 75-unit assisted living community in Parklane, South Carolina and a 46-unit assisted living addition to our Cool Springs, Tennessee community.  At March 31, 2010, we are obligated on construction contracts in the amount of approximately $17,547,000, all of which is expected to require funding within the next twelve months.


We expect to meet our short-term liquidity requirements primarily from our cash flows from operating activities.   In addition to cash flows from operations, our current cash on hand of $27,789,000 at March 31, 2010, marketable securities of $74,358,000 at March 31, 2010 and as needed, our borrowing capacity, are expected to be adequate to meet our contractual obligations and to finance our operating requirements and our growth and development plans in the next twelve months.


Long-term liquidity


Our $75,000,000 revolving credit agreement matures on October 26, 2010.  We currently anticipate renewing the credit agreement at that time and while we have had no indication from the lender that there is any question about renewal, there has been no commitment at this time.  We entered into this loan originally on October 30, 2007, and have renewed the loan twice with one year maturities.  At the inception and at each renewal, the lender offered longer maturities, but the Company chose a one-year maturity because of the terms.  If we are not able to refinance our debt as it matures, we will be required to use our cash and marketable securities to meet our debt obligations and will be limited in our ability to fund future growth opportunities.


Our ability to refinance the credit agreement, to meet our long-term contractual obligations and to finance our operating requirements, growth and development plans will depend upon our future performance, which will be affected




24




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



by business, economic, financial and other factors, including potential changes in state and federal government payment rates for healthcare, customer demand, success of our marketing efforts, pressures from competitors, and the state of the economy, including the state of financial and credit markets.



Guarantees and Contingencies


Debt Guarantees—


At March 31, 2010, we have no guaranteed debt obligations.  


Governmental Regulations –


Laws and regulations governing the Medicare, Medicaid and other federal healthcare programs are complex and subject to interpretation.  Management believes that it is in compliance with all applicable laws and regulations in all material respects.  However, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusions from the Medicare, Medicaid and other federal healthcare programs.  We are not aware of any material regulatory proceeding or investigation underway or threatened involving allegations of potential wrongdoing.


Acquisitions –


We have acquired and will continue to acquire businesses with prior operating histories.  Acquired companies may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, anti-kickback and physician self-referral laws. Although we institute policies designed to conform practices to our standards following completion of acquisitions and attempts to structure our acquisitions as asset acquisitions in which we do not assume liability for seller wrongful actions, there can be no assurance that we will not become liable for past activities that may later be alleged to be improper by private plaintiffs or government agencies.  Although we obtain general indemnifications from sellers covering such matters, there can be no assurance that any specific matter will be covered by such indemnifications, or if covered, that such indemnifications will be adequate to cover potential losses and fines.  



New Accounting Pronouncements


In February 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2010-09, which is included in the Codification under ASC Topic 855, Subsequent Events.  This update removes the requirement for an SEC filer to disclose the date through which subsequent events have been evaluated and became effective immediately.  The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.  


In January 2010, the FASB issued ASU No. 2010-06, which is included in the Codification under ASC Topic 820, Fair Value Measurements and Disclosures.  This update requires the disclosure of transfers between the observable input categories and activity in the unobservable input category for fair value measurements.  The guidance also requires disclosures about the inputs and valuation techniques used to measure fair value and became effective for our interim and annual reporting periods beginning January 1, 2010.  The adoption of this guidance is reflected in Note 7 – Fair Value Measurements.   


In June 2009, the FASB issued ASU No. 2009-17, which is included in the Codification under ASC Topic 810, Consolidation (previously SFAS No. 167, “Amendments to FASB Interpretation No. 46(R)”).  This updated guidance requires an analysis to determine whether a variable interest give the entity a controlling financial interest in a variable




25




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



interest entity.  It also requires an ongoing reassessment and eliminates the quantitative approach previously required for determining whether an entity is the primary beneficiary.  This update is effective for our interim and annual reporting periods beginning January 1, 2010.  The adoption did not have a material impact on the Company’s consolidated financial statements.  



Forward–Looking Statements


References throughout this document to the Company include National HealthCare Corporation and its wholly–owned subsidiaries.  In accordance with the Securities and Exchange Commission=s APlain English@ guidelines, this Quarterly Report on Form 10–Q has been written in the first person.  In this document, the words Awe@, Aour@, Aours@ and Aus@ refer only to National HealthCare Corporation and its wholly–owned subsidiaries and not any other person.


This Quarterly Report on Form 10–Q and other information we provide from time to time, contains certain Aforward–looking@ statements as that term is defined by the Private Securities Litigation Reform Act of 1995.  All statements regarding our expected future financial position, results of operations or cash flows, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities, ability to control our patient care liability costs, ability to respond to changes in government regulations, ability to execute our three–year strategic plan, and similar statements including, without limitations, those containing words such as Abelieves@, Aanticipates@, Aexpects@, Aintends@, Aestimates@, Aplans@, and other similar expressions are forward–looking statements.


Forward–looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward–looking statements as a result of, but not limited to, the following factors:


C

national and local economic conditions, including their effect on the availability and cost of labor, utilities and materials;


C

the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations;


C

changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries;


C

liabilities and other claims asserted against us, including patient care liabilities, as well as the resolution of current litigation (see Note 9:  Guarantees and Contingencies);


C

the ability of third parties for whom we have guaranteed debt, if any, to refinance certain short term debt obligations;


C

the ability to attract and retain qualified personnel;


C

the availability and terms of capital to fund acquisitions and capital improvements;


C

the ability to refinance existing debt on favorable terms;


C

the competitive environment in which we operate;


C

the ability to maintain and increase census levels; and


C

demographic changes.




26




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)




See the notes to the quarterly financial statements, and AItem 1.  Business@ as is found in our 2009 Annual Report on Form 10–K for a discussion of various governmental regulations and other operating factors relating to the healthcare industry and the risk factors inherent in them.  This may be found on our web side at www.nhccare.com.  You should carefully consider these risks before making any investment in the Company.  These risks and uncertainties are not the only ones facing us.  There may be additional risks that we do not presently know of or that we currently deem immaterial.  If any of the risks actually occur, our business, financial condition or results of operations could be materially adversely affected.  In that case, the trading price of our shares of stock could decline, and you may lose all or part of your investment.  Given these risks and uncertainties, we can give no assurances that these forward–looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them.



Item 3.

Quantitative and Qualitative Disclosures About Market Risk.


Interest Rate Risk


Our cash and cash equivalents and restricted cash and cash equivalents consist of highly liquid investments with an original maturity of less than three months.  As a result of the short–term nature of our cash instruments, a hypothetical 10% change in interest rates would have no material impact on our future earnings and cash flows related to these instruments.  


Approximately $20.0 million of our notes receivable bear interest at fixed interest rates.  As the interest rates on these notes receivable are fixed, a hypothetical 10% change in interest rates would have no impact on our future earnings and cash flows related to these instruments.  Approximately $6.2 million of our notes receivable bear interest at variable rates (generally at prime plus 2%). Because the interest rates of these instruments are variable, a hypothetical 10% change in interest rates would result in a related increase or decrease in annual interest income of approximately $33,000.  


As of March 31, 2010 all of our long–term debt bears interest at variable interest rates. Because the interest rates of these instruments are variable, a hypothetical 10% change in interest rates would result in a related increase or decrease in annual interest expense of approximately $28,000.


The investments in restricted marketable securities, which consist of fixed-income debt securities, are primarily exposed to interest rate risk and credit risk.  Generally, the fair value of fixed-income investments moves inversely with movements in market interest rates.  The majority of the fixed-income portfolio is comprised of investments with short-term and intermediate-term maturities, which allows flexibility in reacting to fluctuations of interest rates.  The fixed-income portfolio is managed to achieve an adequate risk-adjusted return while maintaining sufficient liquidity to meet current and intermediate obligations.


Equity Price Risk


We consider our investments in marketable securities as Aavailable for sale@ securities and unrealized gains and losses, net of applicable income taxes, are recorded in stockholders= equity in accordance with ASC Topic 320, Investments – Debt and Equity Securities (previously SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities”).  The investments in marketable securities are recorded at their fair market value based on quoted market prices.  Thus, there is exposure to equity price risk, which is the potential change in fair value due to a change in quoted market price. Hypothetically, a 10% change in quoted market prices would result in a related 10% change in the fair value of our investments in marketable securities.






27




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)



Item 4.  Controls and Procedures.


As of March 31, 2010, an evaluation was performed under the supervision and with the participation of the Company=s management, including the Chief Executive Officer (ACEO@) and Principal Accounting Officer (APAO@), of the effectiveness of the design and operation of the Company=s disclosure controls and procedures.  Based on that evaluation, the Company=s management, including the CEO and PAO, concluded that the Company=s disclosure controls and procedures were effective as of March 31, 2010.  There have been no changes in the Company=s internal control over financial reporting during the quarter ended March 31, 2010 that have materially affected, or are reasonably likely to materially affect, the Company=s internal control over financial reporting.  



PART II.  OTHER INFORMATION


Item 1.  Legal Proceedings.


For a discussion of prior, current and pending litigation of material significance to NHC, please see Note 12 of this Form 10–Q.



Item 1A.  Risk Factors.


During the three months ended March 31, 2010, there were no material changes to the risk factors that were disclosed in Item 1A of National HealthCare Corporation=s Annual Report on Form 10–K for the year ended December 31, 2009.



Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.  Not applicable



Item 3.  Defaults Upon Senior Securities.  None



Item 5.  Other Information.  None



Item 6.  Exhibits.


(a)

List of exhibits

       

Exhibit No.

Description

 

 

31.1

Rule 13a–14(a)/15d–14(a) Certification of Chief Executive Officer

 

 

31.2

Rule 13a–14(a)/15d–14(a) Certification of Principal Financial Officer

 

 

32

Certification pursuant to 18 U.S.C. Section 906 by Chief Executive

 

Officer and Principal Financial Officer








28




NATIONAL HEALTHCARE CORPORATION


March 31, 2010

(unaudited)




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



 

NATIONAL HEALTHCARE CORPORATION

(Registrant)

 

 

Date: May 7, 2010

/s/ Robert G. Adams                                             

 

Robert G. Adams

 

Chief Executive Officer

 

 

Date:  May 7, 2010

 /s/ Donald K. Daniel                                            

 

Donald K. Daniel

 

Senior Vice President and Controller

 

(Principal Accounting Officer)






29